Disclaimer: Institutional Cash Distributors, LLC (“ICD”), a wholly owned subsidiary of ICD Holdings, LLC, archives and reviews outgoing and incoming email. Archived emails may be produced to regulators at their request. Sender accepts no liability for any errors or omissions arising as a result of transmission. This material has been prepared by ICD. It has no regard to the specific investment objectives, financial and risk profiles, or particular needs of any specific recipient. Investors must make their own determination as to the suitability of an investment in any securities referred to herein based on the legal, tax, and accounting considerations applicable to such investors and their own investment strategy. This material is based on information obtained from sources believed to be reliable but no independent verification has been made and its accuracy or completeness is not guaranteed. This document is for information purposes only and should not be regarded as an offer to sell or solicitation to buy the securities or other instruments mentioned. Opinions expressed herein are subject to change without notice. The securities described herein may not be eligible for sale in all jurisdictions or to certain categories of investors. ICD accepts no liability for any loss or damage of any kind arising out of the use of this documents prepared for user information. This/these document/s may not be reproduced or distributed in any manner without the permission of ICD.
Receipt of Prospectus (or other Offering Memorandum) If you would like to receive a copy of a prospectus or offering document for any product offered by ICD, please reply to this email indicating your affirmative consent. By so consenting, you (i) consent to the receipt of such preliminary prospectus and other offering documents via email, (ii) acknowledge that you have the capability to open documents in PDF format on your computer and (iii) acknowledge that if you have any technical difficulties opening the preliminary prospectus in electronic format, you will contact ICD., at the address or telephone number below, to either obtain technical assistance, at no cost to you, in opening the preliminary prospectus in electronic format or a written copy of the preliminary prospectus. You may revoke your consent to receive offering documents via email at any time, either electronically or in writing. Absent your revocation, your consent will remain effective until the completion of the offering. If you do not consent to receiving the offering documents via email, but would still like to receive a written copy of the preliminary prospectus, at no cost to you, please contact:
580 California Street, Suite 1335,
San Francisco, CA 94608,
This communication shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any State/Country in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such State/Country.
ICD is the world’s leading institutional trading and investment risk management company. ICD combines an exceptionally deep selection of liquidity products with superior consolidated reporting and comprehensive exposure analytics. ICD’s Software-as-a-Service Portal™ offers 12 product asset classes, DACOA™ best practices methodologies, award-winning Transparency Plus® 6.0 exposure analytics, dedicated integration services and compliance tools that provide corporate treasury with the industry’s most expansive end-to-end investment trading and risk management solutions.
** Testimonials are not necessarily representative of the experience of others.